Login / Signup
Treatment with angiotensin II in COVID-19 patients may not be beneficial.
Susanne Rysz
Francesca Campoccia Jalde
Anders Oldner
Lars I Eriksson
Johan Lundberg
Malin Jonsson Fagerlund
Published in:
Critical care (London, England) (2020)
Keyphrases
</>
angiotensin ii
angiotensin converting enzyme
vascular smooth muscle cells
sars cov